Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Infliximab Treatment Based on TDM (Therapeutic Drug Monitoring) in Adult Patients With Active Perianal Fistulizing Crohn's Disease

NCT06051253 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06051253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Infliximab Treatment Based on TDM (Therapeutic Drug Monitoring) in Adult Patients With Active Perianal Fistulizing Crohn's Disease
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
November 1, 2023
Completion date
June 30, 2027
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, infliximab, magnetic resonance novel index for fistula imaging in crohn's disease score, perianal fistula due to crohn's disease, therapeutic drug monitoring